U.S., March 17 -- ClinicalTrials.gov registry received information related to the study (NCT07475390) titled 'Molecular Imaging of Brain Tumor Using 99mTc-1-thio-D-glucose SPECT/CT vs 18F-FET PET/CT' on March 11.
Brief Summary: An open-label, single center study with 99mTc-1-thio-D-glucose SPECT/CT and 18F-FET PET/CT in primary and recurrent glioma patients, where the primary endpoint of the study is to compare imaging properties of 99mTc-1-thio-D-glucose SPECT/CT and 18F-FET PET/CT of brain tumor Imaging.
Study Start Date: Feb. 15
Study Type: INTERVENTIONAL
Condition:
Glioma (Any Grade) in the Brain
Intervention:
DRUG: 99mTc-1-thio-D-glucose
One single injection of 99mTc-1-thio-D-glucose, followed by SPECT/CT imaging 1 hour after i...